Capital Fund Management S.A. Biomarin Pharmaceutical Inc Call Options Transaction History

Capital Fund Management S.A.

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2021 May 14, 2021	SELL	$74.73 - $90.69 $1.32 Million - $1.61 Million	-17,700 Reduced 61.89%	10,900 $823,000
Q4 2020 Feb 12, 2021	BUY	$72.61 - $90.2 $2.08 Million - $2.58 Million	28,600 New	28,600 $2.51 Million

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.